GCC Invasive Neurostimulation Devices Market Poised to Hit US$ 82.2 Million by 2033
The GCC invasive neurostimulation devices market is witnessing steady growth, driven by the rising prevalence of neurological disorders and chronic pain, increasing demand for advanced neuromodulation therapies, and improvements in healthcare infrastructure. Invasive neurostimulation devices are used to support the management of chronic pain, movement disorders, and other neurological...